Sara E. Rosenbaum, Ph.D.
Professor of Applied Pharmaceutical Sciences
sarar@uri.edu

Click here for more information about Dr. Rosenbaum

Research Interests:

• Understanding the dose response relationship and factors that effect this relationship. This area is studied through the development and application of pharmacokinetic and pharmacodynamic models.

Wai-Johnn Sam

Background and Research

Dr. Sam’s research interest is in pharmacokinetic /pharmacodynamic modeling using the population approach (as implemented in the program NONMEM) with the aim of optimizing drug development and therapy. In 2005, after receiving his Ph.D. degree in Pharmacy at National University of Singapore, Singapore, Dr. Sam was appointed as a Pfizer joint industrial-academic postdoctoral fellow. In this capacity he is presently working with Dr Sara Rosenbaum at the University of Rhode Island. Current projects include ‘Population Pharmacokinetic Modeling of Mycophenolic Acid and its Metabolites in Kidney Transplant Patients’ (in collaboration with Dr Fatemeh Akhlaghi, University of Rhode Island) and ‘Population Pharmacokinetic/Pharmacodynamic Modeling of AG014447, a Poly(ADP-Ribose)Polymerase Inhibitor, in Cancer Patients’.

Rajesh Narwel
rajesh_ppk@yahoo.com

Background and Research

Rajesh Narwal is a PhD Candidate in Population Pharmacokinetics. He received his B.S in Pharmacy at Guru Jambheshwar University, Hisar, India and his MS in population pharmacokinetics at the University of Rhode Island. Rajesh has worked on a number of projects including: the population pharmacokinetic modeling of prednisolone and population pharmacokinetic and pharmacodynamic modeling of topotecan lactone

Adjunct Faculty

Ene Ette, Ph.D.
Vertex Pharmaceuticals

Marc Gastonguay, Ph.D.,
Metrum Research Group

Diane Mold, Ph.D.,
Projections Research Inc.

© University
of Rhode Island
Disclaimer

The University is an affirmative action/equal opportunity employer.
All rights reserved